| 1 | CCL3
|
| CCL3 Signaling in the Tumor Microenvironment.
|
| Ntanasis-Stathopoulos I, Fotiou D, Terpos E.
|
| Adv Exp Med Biol 1231:13-21. doi: 10.1007/978-3-030-36667-4_2. Review.
2020
|
| 2 | CCL3
|
| CCL3 participates in the development of rheumatoid arthritis by activating AKT.
|
| Zhang G, Liu HB, Zhou L, Cui XQ, Fan XH.
|
| Eur Rev Med Pharmacol Sci 22(20):6625-6632. doi: 10.26355/eurrev_201810_16137.
2018
|
| 3 | CCL3
|
| The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers.
|
| Staversky RJ, Byun DK, Georger MA, Zaffuto BJ, Goodman A, Becker MW, Calvi LM, Frisch BJ.
|
| Sci Rep 8(1):14691. doi: 10.1038/s41598-018-32978-y.
2018
|
| 4 | CCL3
|
| Lack of chemokine (C-C motif) ligand 3 leads to decreased survival and reduced immune response after bacterial meningitis.
|
| Aust V, Kress E, Abraham S, Schröder N, Kipp M, Stope MB, Pufe T, Tauber SC, Brandenburg LO.
|
| Cytokine 111:246-254. doi: 10.1016/j.cyto.2018.09.001. Epub 2018 Sep 7.
2018
|
| 5 | CCL3
|
| The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.
|
| Tsubaki M, Takeda T, Tomonari Y, Mashimo K, Koumoto YI, Hoshida S, Itoh T, Imano M, Satou T, Sakaguchi K, Nishida S.
|
| J Cell Physiol 233(5):4258-4271. doi: 10.1002/jcp.26245. Epub 2017 Nov 16.
2018
|
| 6 | CCL3, CCL4
|
| Decreased macrophage inflammatory protein (MIP)-1α and MIP-1β increase the risk of developing nasopharyngeal carcinoma.
|
| Yang MJ, Guo J, Ye YF, Chen SH, Peng LX, Lin CY, Hu T, Xie SH, Xie CB, Huang QH, Lu YQ, Liu Q, Qian CN, Cao SM.
|
| Cancer Commun (Lond) 38(1):7. doi: 10.1186/s40880-018-0279-y.
2018
|
| 7 | CCL3
|
| Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3.
|
| Wang Y, Gao A, Zhao H, Lu P, Cheng H, Dong F, Gong Y, Ma S, Zheng Y, Zhang H, Zhang Y, Xu J, Zhu X, Yuan W, Zhang X, Hao S, Cheng T.
|
| Leukemia 30(9):1897-908. doi: 10.1038/leu.2016.81. Epub 2016 Apr 25.
2016
|
| 8 | CCL3, CCL5
|
| Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3.
|
| Liang WG, Triandafillou CG, Huang TY, Zulueta MM, Banerjee S, Dinner AR, Hung SC, Tang WJ.
|
| Proc Natl Acad Sci U S A 113(18):5000-5. doi: 10.1073/pnas.1523981113. Epub 2016 Apr 18.
2016
|
| 9 | CCL3, CCL4
|
| T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.
|
| Patterson SJ, Pesenacker AM, Wang AY, Gillies J, Mojibian M, Morishita K, Tan R, Kieffer TJ, Verchere CB, Panagiotopoulos C, Levings MK.
|
| J Clin Invest 126(3):1039-51. doi: 10.1172/JCI83987. Epub 2016 Feb 8.
2016
|
| 10 | CCL14, CCL2, CCL3
|
| Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma.
|
| Li Y, Zheng Y, Li T, Wang Q, Qian J, Lu Y, Zhang M, Bi E, Yang M, Reu F, Yi Q, Cai Z.
|
| Oncotarget 6(27):24218-29.
2015
|
| 11 | CCL3
|
| The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory.
|
| Marciniak E, Faivre E, Dutar P, Alves Pires C, Demeyer D, Caillierez R, Laloux C, Buée L, Blum D, Humez S.
|
| Sci Rep 5:15862. doi: 10.1038/srep15862.
2015
|
| 12 | CCL3, EPO
|
| Erythropoietin and CCL3 antagonise their functional properties during neuroinflammation.
|
| Hattermann K, Knerlich-Lukoschus F, Lucius R, Mehdorn M, Held-Feindt J.
|
| Neurol Res 37(11):1025-8. doi: 10.1179/1743132815Y.0000000070. Epub 2015 Jul 16.
2015
|
| 13 | CCL3
|
| Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
|
| Ravi AK, Khurana S, Lemon J, Plumb J, Booth G, Healy L, Catley M, Vestbo J, Singh D.
|
| Respir Res 15:103. doi: 10.1186/s12931-014-0103-4.
2014
|
| 14 | CCL2, CCL3
|
| Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.
|
| Ding L, Li B, Zhao Y, Fu YF, Hu EL, Hu QG, Ni YH, Hou YY.
|
| Tumour Biol 35(10):10539-46. doi: 10.1007/s13277-014-2306-1. Epub 2014 Jul 25.
2014
|
| 15 | CCL3
|
| CCL3 production by microglial cells modulates disease severity in murine models of retinal degeneration.
|
| Kohno H, Maeda T, Perusek L, Pearlman E, Maeda A.
|
| J Immunol 192(8):3816-27. doi: 10.4049/jimmunol.1301738. Epub 2014 Mar 17.
2014
|
| 16 | CCL2, CCL3
|
| Epigenetic upregulation of CCL2 and CCL3 via histone modifications in infiltrating macrophages after peripheral nerve injury.
|
| Kiguchi N, Kobayashi Y, Saika F, Kishioka S.
|
| Cytokine 64(3):666-72. doi: 10.1016/j.cyto.2013.09.019. Epub 2013 Oct 14.
2013
|
| 17 | CCL3
|
| Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation.
|
| de Jager SC, Bot I, Kraaijeveld AO, Korporaal SJ, Bot M, van Santbrink PJ, van Berkel TJ, Kuiper J, Biessen EA.
|
| Arterioscler Thromb Vasc Biol 33(3):e75-83. doi: 10.1161/ATVBAHA.112.300857. Epub 2013 Jan 3.
2013
|
| 18 | CCL3
|
| CCL3 induced migration occurs independently of intracellular calcium release.
|
| Moyano Cardaba C, Jacques RO, Barrett JE, Hassell KM, Kavanagh A, Remington FC, Tse T, Mueller A.
|
| Biochem Biophys Res Commun 418(1):17-21. doi: 10.1016/j.bbrc.2011.12.081. Epub 2011 Dec 22.
2012
|
| 19 | CCL3, ZFP36
|
| Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation.
|
| Kang JG, Amar MJ, Remaley AT, Kwon J, Blackshear PJ, Wang PY, Hwang PM.
|
| J Immunol 187(5):2696-701. Epub 2011 Jul 22.
2011
|
| 20 | CCL2, CCL3, CCL4, CCL5
|
| Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.
|
| Neumeier M, Bauer S, Brühl H, Eisinger K, Kopp A, Abke S, Walter R, Schäffler A, Buechler C.
|
| Cytokine 56(3):573-80. doi: 10.1016/j.cyto.2011.08.017. Epub 2011 Sep 3. Erratum in: Cytokine. 2013 Jun;62(3):453.
2011
|
| 21 | CCL3
|
| Chronic exposure to the chemokine CCL3 enhances neuronal network activity in rat hippocampal cultures.
|
| Kuijpers M, van Gassen KL, de Graan PN, Gruol D.
|
| J Neuroimmunol Neuroimmunol. 2010 Jul 31. [Epub ahead of print]PMID: 20678811 2010
|
| 22 | CCL3
|
| Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells.
|
| Zhao L, Toriumi H, Wang H, Kuang Y, Guo X, Morimoto K, Fu ZF.
|
| J Virol 84(18):9642-8. Epub 2010 Jun 30.PMID: 20592092 2010
|
| 23 | CCL3, CCL4
|
| Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme.
|
| Ren M, Guo Q, Guo L, Lenz M, Qian F, Koenen RR, Xu H, Schilling AB, Weber C, Ye RD, Dinner AR, Tang WJ.
|
| EMBO J 29(23):3952-66. doi: 10.1038/emboj.2010.256. Epub 2010 Oct 19.
2010
|
| 24 | CCL3
|
| Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis.
|
| Shehadeh N, Pollack S, Wildbaum G, Zohar Y, Shafat I, Makhoul R, Daod E, Hakim F, Perlman R, Karin N.
|
| J Immunol 182(12):8104-9.PMID: 19494336 2009
|
| 25 | CCL3, CCL4
|
| Possible role of the innate immunity in temporal lobe epilepsy.
|
| van Gassen KL, de Wit M, Koerkamp MJ, Rensen MG, van Rijen PC, Holstege FC, Lindhout D, de Graan PN.
|
| Epilepsia 49(6):1055-65. Epub 2007 Dec 11.PMID: 18076643 2008
|
| 26 | CCL3, CCR5
|
| CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process.
|
| Wu Y, Li YY, Matsushima K, Baba T, Mukaida N.
|
| J Immunol 181(9):6384-93.PMID: 18941229 2008
|
| 27 | CCL3
|
| CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events.
|
| de Jager SC, Kraaijeveld AO, Grauss RW, de Jager W, Liem SS, van der Hoeven BL, Prakken BJ, Putter H, van Berkel TJ, Atsma DE, Schalij MJ, Jukema JW, Biessen EA.
|
| J Mol Cell Cardiol 45(3):446-52. Epub 2008 Jun 21.PMID: 18619972 2008
|
| 28 | CCL3, CCL4, CCL18
|
| Genetic Variation in the CCL18-CCL3-CCL4 Chemokine Gene Cluster Influences HIV Type 1 Transmission and AIDS Disease Progression.
|
| Modi WS, Lautenberger J, An P, Scott K, Goedert JJ, Kirk GD, Buchbinder S, Phair J, Donfield S, O'brien SJ, Winkler C.
|
| Am J Hum Genet 79(1):120-8. Epub 2006 May 30. 2006
|
| 29 | CCL3L1, CCL3, CCL4, CCL4L1
|
| CCL3L1 and CCL4L1 chemokine genes are located in a segmental duplication at chromosome 17q12.
|
| Modi WS.
|
| Genomics 83(4):735-8. 2004
|
| 30 | CCL3L1, CCL4L1, CCL3
|
| Gene copy number regulates the production of the human chemokine CCL3-L1.
|
| Townson JR, Barcellos LF, Nibbs RJ.
|
| Eur J Immunol 32(10):3016-26. 2002
|
| 31 | CCL3, CCL4, CCL4L1, CCL5, CCL7, CCL11, CCL13, CCL20, CXCL12
|
| Chemokines--chemotactic cytokines that mediate inflammation.
|
| Luster AD.
|
| N Engl J Med 338(7):436-45. Review. No abstract available. 1998
|
| 32 | CCL3
|
| The gene encoding the Act-2 cytokine. Genomic structure, HTLV-I/Tax responsiveness of 5' upstream sequences, and chromosomal localization.
|
| Napolitano M, et al.
|
| J Biol Chem 266 : 17531-17536. 1991
|
| 33 | CCL3, CCL4, CCL4L1, CCL3L1, CXCL2
|
| Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q.
|
| Irving SG, et al.
|
| Nucleic Acids Res 18 : 3261-3270. 1990
|
| 34 | CCL3, CCL3L1, CCL3L2, CCL3L3
|
| Structures of human genes coding for cytokine LD78 and their expression.
|
| Nakao M, Nomiyama H, Shimada K.
|
| Mol Cell Biol 10(7):3646-58. 1990
|